Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06252675
Title Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors C. Babis Andreadis
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.